Healthcare provider profile · identity verified

Andrew Wormser, MD

Internal Medicine · NEW HAVEN, CT · NPI 1649279167

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1257	369
Amlodipine Besylate	Amlodipine Besylate	521	155
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	279	79
Lisinopril	Lisinopril	240	67
Metformin Hcl	Metformin Hcl	225	66
Levothyroxine Sodium	Levothyroxine Sodium	219	59
Hydrochlorothiazide	Hydrochlorothiazide	191	50
Losartan Potassium	Losartan Potassium	142	38
Allopurinol	Allopurinol	135	43
Potassium Chloride	Potassium Chloride	124	35
Rosuvastatin Calcium	Rosuvastatin Calcium	123	38
Metoprolol Succinate	Metoprolol Succinate	118	33
Jardiance	Empagliflozin	110	31
Omeprazole	Omeprazole	106	31
Lorazepam	Lorazepam	105	31
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	105	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	105	35
Alprazolam	Alprazolam	94	25
Gabapentin	Gabapentin	90	36
Metformin Hcl Er	Metformin Hcl	82	25
Ibandronate Sodium	Ibandronate Sodium	75	23
Fluoxetine Hcl	Fluoxetine Hcl	74	20
Tamsulosin Hcl	Tamsulosin Hcl	72	22
Valsartan	Valsartan	71	19
Eliquis	Apixaban	69	22
Pravastatin Sodium	Pravastatin Sodium	69	20
Glimepiride	Glimepiride	67	21
Synthroid	Levothyroxine Sodium	65	17
Atenolol	Atenolol	64	16
Citalopram Hbr	Citalopram Hydrobromide	62	20
Montelukast Sodium	Montelukast Sodium	61	22
Ezetimibe	Ezetimibe	60	17
Albuterol Sulfate Hfa	Albuterol Sulfate	59	27
Chlorthalidone	Chlorthalidone	59	19
Escitalopram Oxalate	Escitalopram Oxalate	57	14
Famotidine	Famotidine	57	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	33
Simvastatin	Simvastatin	54	15
Tramadol Hcl	Tramadol Hcl	50	19
Ozempic	Semaglutide	45	suppressed
Furosemide	Furosemide	41	19
Carvedilol	Carvedilol	40	12
Metoprolol Tartrate	Metoprolol Tartrate	39	suppressed
Trazodone Hcl	Trazodone Hcl	39	16
Zolpidem Tartrate	Zolpidem Tartrate	38	suppressed
Irbesartan	Irbesartan	37	11
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	35	12
Paxlovid	Nirmatrelvir/Ritonavir	35	33
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Mirtazapine	Mirtazapine	34	13
Spironolactone	Spironolactone	34	15
Clopidogrel	Clopidogrel Bisulfate	33	11
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	suppressed
Felodipine Er	Felodipine	30	suppressed
Rybelsus	Semaglutide	30	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	28	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	28	suppressed
Sertraline Hcl	Sertraline Hcl	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	12
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Perphenazine	Perphenazine	25	suppressed
Valacyclovir	Valacyclovir Hcl	25	13
Enalapril Maleate	Enalapril Maleate	24	suppressed
Lovastatin	Lovastatin	24	suppressed
Bupropion Xl	Bupropion Hcl	23	suppressed
Clonazepam	Clonazepam	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Finasteride	Finasteride	22	suppressed
Klor-Con M10	Potassium Chloride	22	suppressed
Methylprednisolone	Methylprednisolone	22	17
Mounjaro	Tirzepatide	22	suppressed
Telmisartan	Telmisartan	22	suppressed
Amoxicillin	Amoxicillin	21	13
Ketoconazole	Ketoconazole	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Farxiga	Dapagliflozin Propanediol	20	suppressed
Fluocinonide	Fluocinonide	20	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	20	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Meclizine Hcl	Meclizine Hcl	19	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	19	suppressed
Oxycodone Hcl	Oxycodone Hcl	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Prednisone	Prednisone	19	suppressed
Indapamide	Indapamide	17	suppressed
Januvia	Sitagliptin Phosphate	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	11
Colchicine	Colchicine	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Azithromycin	Azithromycin	15	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Glipizide	Glipizide	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Naltrexone Hcl	Naltrexone Hcl	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fluticasone Propionate Hfa	Fluticasone Propionate	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Cephalexin	Cephalexin	12	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Latanoprost	Latanoprost	12	suppressed
Lithium Carbonate	Lithium Carbonate	12	suppressed
Tradjenta	Linagliptin	12	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error